View ValuationChemed 향후 성장Future 기준 점검 0/6Chemed은 연간 수입과 매출이 각각 7.4%와 5.1% 증가할 것으로 예상되고 EPS는 연간 10.9%만큼 증가할 것으로 예상됩니다.핵심 정보7.4%이익 성장률10.85%EPS 성장률Healthcare 이익 성장20.2%매출 성장률5.1%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트21 Sep 2025최근 향후 성장 업데이트공시 • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.공시 • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.공시 • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.모든 업데이트 보기Recent updates공시 • May 20Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 16, 2026Chemed Corporation at the annual stockholders’ meeting held on May 18, 2026 declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026.공시 • Apr 07Chemed Corporation, Annual General Meeting, May 18, 2026Chemed Corporation, Annual General Meeting, May 18, 2026. Location: queen city club, 331 east fourth street, cincinnati, ohio, United States공시 • Apr 02Chemed Corporation to Report Q1, 2026 Results on Apr 23, 2026Chemed Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2026공시 • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.공시 • Feb 14Chemed Corporation Declares Quarterly Cash Dividend, Payable on March 13, 2026Chemed Corporation announced the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.공시 • Jan 03Chemed Corporation to Report Q4, 2025 Results on Feb 25, 2026Chemed Corporation announced that they will report Q4, 2025 results After-Market on Feb 25, 2026공시 • Nov 07Chemed Corporation Declares Quarterly Cash Dividend, Payable on December 5, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.공시 • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.공시 • Oct 01Chemed Corporation to Report Q3, 2025 Results on Oct 28, 2025Chemed Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Oct 28, 2025공시 • Aug 02Chemed Corporation Declares Quarterly Cash Dividend on Capital Stock, Payable on August 29, 2025The Board of Directors of Chemed Corporation has declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10 cents, or 20.0%, increase over the 50 cents dividend paid in June 2025.공시 • Jul 30+ 1 more updateChemed Corporation Announces Departure of Nicholas M. Westfall as Executive Vice President, Effective December 1, 2025Chemed Corporation (company) announced that after a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS Healthcare Corporation (VITAS), Nicholas M. Westfall, has announced that he is departing the company to pursue other personal and professional opportunities. Mr. Westfall will continue to work with the Company until December 1, 2025 to ensure an orderly transition. Mr. Westfall has been with Chemed since May 2009. He transitioned to the role of Senior Vice President of Operations at VITAS in 2012 and was promoted to Chief Operating Officer in 2015. Mr. Westfall has been serving as an Executive Vice President of Chemed and Chief Executive Officer of VITAS since June 2016 and was named Chairman and Chief Executive Officer of VITAS in 2024.공시 • Jun 28Chemed Corporation to Report Q2, 2025 Results on Jul 29, 2025Chemed Corporation announced that they will report Q2, 2025 results After-Market on Jul 29, 2025공시 • May 20Chemed Corporation Declares Quarterly Dividend, Payable on June 17, 2025Chemed Corporation declared a quarterly cash dividend of 50 cents per share on the Company’s capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed’s 54 years as a public company.공시 • Apr 03Chemed Corporation, Annual General Meeting, May 19, 2025Chemed Corporation, Annual General Meeting, May 19, 2025.공시 • Apr 01Chemed Corporation to Report Q1, 2025 Results on Apr 23, 2025Chemed Corporation announced that they will report Q1, 2025 results After-Market on Apr 23, 2025공시 • Feb 15Chemed Corporation Declares Quarterly Dividend, Payable on March 14, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025.공시 • Feb 12Chemed Corporation to Report Q4, 2024 Results on Feb 26, 2025Chemed Corporation announced that they will report Q4, 2024 results After-Market on Feb 26, 2025Recent Insider Transactions • Dec 03CEO, President & Director recently sold Mex$23m worth of stockOn the 25th of November, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,650 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth Mex$23m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$128m.공시 • Nov 08Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024Chemed Corporation declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214 consecutive quarterly dividend paid by Chemed in its 53 years as a public company.공시 • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.Recent Insider Transactions • Sep 28CEO, President & Director recently sold Mex$23m worth of stockOn the 26th of September, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,710 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$135m.공시 • Sep 14Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024Chemed Corporation announced that they will report Q3, 2024 results After-Market on Oct 29, 2024Recent Insider Transactions • Sep 11Executive Vice President recently sold Mex$19m worth of stockOn the 9th of September, Nicholas Westfall sold around 2k shares on-market at roughly Mex$11,323 per share. This transaction amounted to 22% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Insiders have been net sellers, collectively disposing of Mex$434m more than they bought in the last 12 months.이익 및 매출 성장 예측BMV:CHE * - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20272,819N/AN/AN/A112/31/20262,720319383437412/31/20252,54927936842446/30/20252,512290371427N/A3/31/20252,489309315366N/A12/31/20242,431302368417N/A9/30/20242,377302313361N/A6/30/20242,336301253300N/A3/31/20242,293283302354N/A12/31/20232,264273273330N/A9/30/20232,225245259322N/A6/30/20232,187226280345N/A3/31/20232,165240208269N/A12/31/20222,135250253310N/A9/30/20222,129262220273N/A6/30/20222,141277284334N/A3/31/20222,142267249303N/A12/31/20212,139269250309N/A9/30/20212,132308271332N/A6/30/20212,121303283344N/A3/31/20212,091329450507N/A12/31/20202,080319430489N/A9/30/20202,069271410466N/A6/30/20202,021263413470N/A3/31/20201,992231258317N/A12/31/20191,939220248301N/A9/30/20191,874209238294N/A6/30/20191,837201218275N/A3/31/20191,806205N/A296N/A12/31/20181,783206N/A287N/A9/30/20181,753206N/A202N/A6/30/20181,727190N/A183N/A3/31/20181,700113N/A159N/A12/31/20171,66798N/A162N/A9/30/20171,64276N/A198N/A6/30/20171,61767N/A162N/A3/31/20171,592114N/A197N/A12/31/20161,577109N/A135N/A9/30/20161,572106N/A187N/A6/30/20161,566108N/A175N/A3/31/20161,557111N/A166N/A12/31/20151,543110N/A172N/A9/30/20151,524110N/A172N/A6/30/20151,496106N/A135N/A3/31/20151,475103N/A134N/A12/31/20141,45699N/A110N/A9/30/20141,42592N/A66N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: CHE * 의 연간 예상 수익 증가율(7.4%)이 saving rate(8.5%) 미만입니다.수익 vs 시장: CHE * 의 연간 수익(7.4%)이 MX 시장(8.8%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: CHE * 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: CHE * 의 수익(연간 5.1%)이 MX 시장(연간 6.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: CHE * 의 수익(연간 5.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: CHE *의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/09/27 17:58종가2025/06/30 00:00수익2025/06/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Chemed Corporation는 10명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Adam FeinsteinBarclaysJoanna Sylvia GajukBofA Global ResearchPeter MartinCitizens JMP Securities, LLC7명의 분석가 더 보기
공시 • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.
공시 • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.
공시 • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.
공시 • May 20Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 16, 2026Chemed Corporation at the annual stockholders’ meeting held on May 18, 2026 declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026.
공시 • Apr 07Chemed Corporation, Annual General Meeting, May 18, 2026Chemed Corporation, Annual General Meeting, May 18, 2026. Location: queen city club, 331 east fourth street, cincinnati, ohio, United States
공시 • Apr 02Chemed Corporation to Report Q1, 2026 Results on Apr 23, 2026Chemed Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2026
공시 • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.
공시 • Feb 14Chemed Corporation Declares Quarterly Cash Dividend, Payable on March 13, 2026Chemed Corporation announced the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
공시 • Jan 03Chemed Corporation to Report Q4, 2025 Results on Feb 25, 2026Chemed Corporation announced that they will report Q4, 2025 results After-Market on Feb 25, 2026
공시 • Nov 07Chemed Corporation Declares Quarterly Cash Dividend, Payable on December 5, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.
공시 • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.
공시 • Oct 01Chemed Corporation to Report Q3, 2025 Results on Oct 28, 2025Chemed Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Oct 28, 2025
공시 • Aug 02Chemed Corporation Declares Quarterly Cash Dividend on Capital Stock, Payable on August 29, 2025The Board of Directors of Chemed Corporation has declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10 cents, or 20.0%, increase over the 50 cents dividend paid in June 2025.
공시 • Jul 30+ 1 more updateChemed Corporation Announces Departure of Nicholas M. Westfall as Executive Vice President, Effective December 1, 2025Chemed Corporation (company) announced that after a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS Healthcare Corporation (VITAS), Nicholas M. Westfall, has announced that he is departing the company to pursue other personal and professional opportunities. Mr. Westfall will continue to work with the Company until December 1, 2025 to ensure an orderly transition. Mr. Westfall has been with Chemed since May 2009. He transitioned to the role of Senior Vice President of Operations at VITAS in 2012 and was promoted to Chief Operating Officer in 2015. Mr. Westfall has been serving as an Executive Vice President of Chemed and Chief Executive Officer of VITAS since June 2016 and was named Chairman and Chief Executive Officer of VITAS in 2024.
공시 • Jun 28Chemed Corporation to Report Q2, 2025 Results on Jul 29, 2025Chemed Corporation announced that they will report Q2, 2025 results After-Market on Jul 29, 2025
공시 • May 20Chemed Corporation Declares Quarterly Dividend, Payable on June 17, 2025Chemed Corporation declared a quarterly cash dividend of 50 cents per share on the Company’s capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed’s 54 years as a public company.
공시 • Apr 03Chemed Corporation, Annual General Meeting, May 19, 2025Chemed Corporation, Annual General Meeting, May 19, 2025.
공시 • Apr 01Chemed Corporation to Report Q1, 2025 Results on Apr 23, 2025Chemed Corporation announced that they will report Q1, 2025 results After-Market on Apr 23, 2025
공시 • Feb 15Chemed Corporation Declares Quarterly Dividend, Payable on March 14, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025.
공시 • Feb 12Chemed Corporation to Report Q4, 2024 Results on Feb 26, 2025Chemed Corporation announced that they will report Q4, 2024 results After-Market on Feb 26, 2025
Recent Insider Transactions • Dec 03CEO, President & Director recently sold Mex$23m worth of stockOn the 25th of November, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,650 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth Mex$23m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$128m.
공시 • Nov 08Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024Chemed Corporation declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214 consecutive quarterly dividend paid by Chemed in its 53 years as a public company.
공시 • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.
Recent Insider Transactions • Sep 28CEO, President & Director recently sold Mex$23m worth of stockOn the 26th of September, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,710 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$135m.
공시 • Sep 14Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024Chemed Corporation announced that they will report Q3, 2024 results After-Market on Oct 29, 2024
Recent Insider Transactions • Sep 11Executive Vice President recently sold Mex$19m worth of stockOn the 9th of September, Nicholas Westfall sold around 2k shares on-market at roughly Mex$11,323 per share. This transaction amounted to 22% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Insiders have been net sellers, collectively disposing of Mex$434m more than they bought in the last 12 months.